Basic Information
| LncRNA/CircRNA Name | CASC9.5 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, Western blot, in vitro knockdown, RNAi, RIP |
| Sample | lung adenocarcinoma tissue, lung adenocarcinomar cell lines (A549 and SPC-A1) |
| Expression Pattern | up-regulated |
| Function Description | CASC9.5 expression levels were significantly higher in lung cancer tissues and cells compared with normal lung tissues.CASC9.5 promoted lung adenocarcinoma cell proliferation and metabolism by regulating the expression levels of cyclin D1, E-cadherin, N-cadherin and B-catenin. |
| Pubmed ID | 29311567 |
| Year | 2018 |
| Title | Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. |
External Links
| Links for CASC9.5 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |